| Literature DB >> 35155478 |
Tian Li1, Jing Yuan Liu1, Jing Feng Liu2, Meili Duan2, Ang Li1.
Abstract
BACKGROUND: Acute kidney injury (AKI) is a common complication of sepsis and is an independent risk factor for mortality. It is unclear whether different bacteria play different roles in the occurrence and development of sepsis-associated AKI (S-AKI). We observed the clinical characteristics and outcomes of patients that have types of bacterial infection, and different infections sites before the occurrence of AKI, respectively.Entities:
Keywords: acute kidney injury; clinical outcome; gram-negative bacteria; gram-positive bacteria; sepsis
Year: 2022 PMID: 35155478 PMCID: PMC8828919 DOI: 10.3389/fmed.2021.800532
Source DB: PubMed Journal: Front Med (Lausanne) ISSN: 2296-858X
Figure 1The flowchart of the study population. Data were retrieved from the MIMIC database IV.
The baseline characteristics and clinical outcomes of patients with sepsis-associated acute kidney injury (S-AKI) among groups.
|
|
|
| ||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| Age (years) | 70.0 [57.0; 79.0] | 66.0 [55.0; 77.0] | <0.001 | 69.0 [55.0; 80.0] | 62.0 [49.8; 74.2] | 0.004 |
| Gender | <0.001 | 0.292 | ||||
| Female, | 265 (49.3%) | 484 (38.8%) | 46 (49.5%) | 112 (42.4%) | ||
| Male, | 272 (50.7%) | 764 (61.2%) | 47 (50.5%) | 152 (57.6%) | ||
| BMI (IQR) | 27.0 [23.1; 32.5] | 28.4 [24.4; 34.3] | <0.001 | 27.3 [23.9; 34.1] | 28.1 [24.3; 33.5] | 0.901 |
| Smoker, | 62 (11.5%) | 125 (10.0%) | 0.377 | 7 (7.53%) | 32 (12.1%) | 0.304 |
| Alcohol, | 41 (7.64%) | 120 (9.62%) | 0.211 | 5 (5.38%) | 28 (10.6%) | 0.197 |
| Vasopressor, | 335 (62.4%) | 757 (60.7%) | 0.526 | 68 (73.1%) | 149 (56.4%) | 0.007 |
| SOFA score (IQR) | 8.00 [5.00; 11.0] | 7.00 [5.00; 10.2] | 0.079 | 10.0 [7.00; 13.0] | 9.00 [5.75; 12.0] | 0.005 |
| APSIII score | 63.0 [47.0; 82.0] | 58.0 [39.0; 80.0] | 0.001 | 72.0 [56.0; 94.0] | 65.5 [50.0; 90.0] | 0.114 |
| AKI stage, | 0.518 | 0.514 | ||||
| 1 | 117 (21.8%) | 248 (19.9%) | 14 (15.1%) | 54 (20.5%) | ||
| 2 | 248 (46.2%) | 610 (48.9%) | 40 (43.0%) | 104 (39.4%) | ||
| 3 | 172 (32.0%) | 390 (31.2%) | 39 (41.9%) | 106 (40.2%) | ||
| CKD stage I, | 0 (0%) | 0 (0%) | . | 0 (0%) | 0 (0%) | . |
| CKD stage II, | 6 (1.12%) | 6 (0.48%) | 0.202 | 2 (2.15%) | 2 (0.76%) | 0.279 |
| CKD stage III, | 28 (5.21%) | 57 (4.57%) | 0.64 | 7 (7.53%) | 10 (3.79%) | 0.16 |
| CKD stage IV, | 6 (1.12%) | 29 (2.32%) | 0.134 | 1 (1.08%) | 4 (1.52%) | 1 |
| CKD stage V, | 1 (0.19%) | 3 (0.24%) | 1 | 1 (1.08%) | 0 (0.00%) | 0.261 |
| Chronic pulmonary | 188 (35.0%) | 385 (30.8%) | 0.095 | 24 (25.8%) | 69 (26.1%) | 1 |
| ARDS, | 8 (1.49%) | 10 (0.80%) | 0.282 | 1 (1.08%) | 4 (1.52%) | 1 |
| Hypertension, | 275 (51.2%) | 615 (49.3%) | 0.486 | 50 (53.8%) | 114 (43.2%) | 0.101 |
| Heart failure, | 65 (12.1%) | 176 (14.1%) | 0.29 | 14 (15.1%) | 47 (17.8%) | 0.656 |
| Diabetes without cc, | 139 (25.9%) | 339 (27.2%) | 0.616 | 28 (30.1%) | 68 (25.8%) | 0.498 |
| Diabetes with cc, | 44 (8.19%) | 127 (10.2%) | 0.223 | 11 (11.8%) | 26 (9.85%) | 0.733 |
| Creatinine (IQR) | 1.2 [0.8; 1.8] | 1.2 [0.9; 1.9] | 0.409 | 1.6 [1.0; 2.5] | 1.3 [0.9; 2.4] | 0.228 |
| Urea nitrogen (IQR) | 25.0 [17.0; 42.0] | 25.0 [16.0; 42.0] | 0.955 | 29.0 [18.0; 44.0] | 32.5 [18.0; 52.0] | 0.472 |
| Lactate (IQR) | 2.5 [1.6; 4.0] | 2.4 [1.7; 3.7] | 0.878 | 3.7 [2.2; 5.5] | 2.5 [1.6; 4.4] | 0.001 |
| Glucose (IQR) | 151.0 [124.0; 207.0] | 145.5 [118.0; 202.0] | 0.066 | 163.0 [125.0; 221.0] | 158.5 [127.0; 221.2] | 0.926 |
| Anion gap (IQR) | 17.0 [14.0; 19.0] | 16.0 [13.0; 19.0] | 0.011 | 18.0 [16.0; 21.0] | 17.0 [14.0; 20.0] | 0.017 |
| Epithelial cells (IQR) | 76 (14.2%) | 145 (11.6%) | 0.158 | 21 (22.6%) | 40 (15.2%) | 0.14 |
| Total input before AKI diagnosis, (IQR) | 3309.8 [1613.5; 7100.5] | 3236.9 [1750.3; 5674.3] | 0.235 | 3216.5 [1721.8; 5879.8] | 2922.7 [1498.6; 6875.4] | 0.868 |
| Total output before AKI diagnosis (IQR) | 1640.0 [590.0; 4420.0] | 1650.0 [648.0; 3701.8] | 0.609 | 1000.0 [470.0; 1970.0] | 1417.5 [273.8; 4168.8] | 0.15 |
| Fluid balance before AKI diagnosis (IQR) | 1353.2 [125.0; 3093.6] | 1235.6 [163.5; 2953.3] | 0.64 | 1943.8 [352.3; 4063.7] | 1393.5 [248.2; 3527.6] | 0.233 |
| CRRT, | 42 (7.82%) | 78 (6.25%) | 0.266 | 15 (16.1%) | 27 (10.2%) | 0.183 |
| Time from positive microbial culture to diagnosis of AKI, | 2.94 [1.81; 3.90] | 3.16 [2.02; 4.06] | 0.013 | 2.23 [1.64; 3.08] | 3.00 [1.87; 4.23] | 0.001 |
| Los hospital (IQR) | 12.5 [7.66; 20.7] | 12.0 [6.97; 20.9] | 0.426 | 13.8 [7.78; 24.9] | 14.9 [7.71; 25.9] | 0.904 |
| Los ICU (IQR) | 5.94 [3.18; 11.0] | 4.77 [2.42; 9.13] | <0.001 | 5.19 [2.75; 11.7] | 5.73 [2.95; 9.89] | 0.785 |
| Death in ICU, | 75 (14.0%) | 193 (15.5%) | 0.459 | 13 (14.0%) | 60 (22.7%) | 0.099 |
| Death in hospital, | 107 (19.9%) | 264 (21.2%) | 0.601 | 23 (24.7%) | 85 (32.2%) | 0.224 |
Figure 2Main sites of infection and the top five bacteria in each site.
Multivariate Cox regression analysis of the correlation between variables and intensive care unit (ICU) mortality among groups.
|
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |
| Age | 1.02 (1.00, 1.05) | 0.098 | 1.01 (1.00, 1.02) | 0.046 | 1.03 (0.93, 1.15) | 0.556 | 1.00 (0.99, 1.02) | 0.748 |
| Gender = male | 1.35 (0.72, 2.54) | 0.349 | 1.13 (0.81, 1.57) | 0.482 | 2.49 (0.28, 22.08) | 0.411 | 1.21 (0.66, 2.21) | 0.541 |
| SOFA score | 0.92 (0.79, 1.07) | 0.252 | 1.03 (0.95, 1.11) | 0.451 | 1.15 (0.56, 2.38) | 0.698 | 1.09 (0.95, 1.24) | 0.221 |
| Lactate | 1.17 (1.00, 1.36) | 0.047 | 1.06 (0.99, 1.13) | 0.117 | 0.81 (0.41, 1.60) | 0.54 | 1.03 (0.91, 1.15) | 0.661 |
| APS III score | 1.02 (1.01, 1.04) | 0.006 | 1.02 (1.01, 1.02) | <0.001 | 0.99 (0.91, 1.08) | 0.852 | 1.00 (0.99, 1.02) | 0.64 |
| AKI stage | 1.08 (0.66, 1.76) | 0.772 | 1.53 (1.15, 2.04) | 0.004 | 11.28(0.33,389.45) | 0.18 | 1.64 (0.94, 2.88) | 0.083 |
| CRRT | 1.43 (0.60, 3.39) | 0.423 | 1.58 (0.97, 2.57) | 0.066 | 4.45 (0.12, 171.78) | 0.424 | 3.48 (1.35, 8.98) | 0.01 |
| Los hospital | 0.18 (0.13, 0.25) | <0.001 | 0.53 (0.48, 0.58) | <0.001 | 0.35 (0.19, 0.63) | <0.001 | 0.67 (0.59, 0.75) | <0.001 |
| Los ICU | 1.33 (1.13, 1.58) | <0.001 | 1.13 (1.06, 1.20) | <0.001 | 1.42 (0.94, 2.15) | 0.096 | 1.03 (0.95, 1.13) | 0.47 |
Figure 3Comparison of Kaplan–Meier survival curves between groups. (A) 28-days mortality of intensive care unit (ICU) in patients with bacteria culture Gram-positive and Gram-negative. (B) 60-days mortality of ICU in patients with bacteria culture Gram-positive and Gram-negative. (C) 28-days mortality in ICU of Gram-negative bacteria group and positive bacteria group in patients with positive blood culture. (D) 60-days mortality in ICU of Gram-negative bacteria group and positive bacteria group in patients with positive blood culture.